DE68907406D1 - DEPRENYL FOR SYSTEMIC TRANSDERMAL USE. - Google Patents

DEPRENYL FOR SYSTEMIC TRANSDERMAL USE.

Info

Publication number
DE68907406D1
DE68907406D1 DE8989903719T DE68907406T DE68907406D1 DE 68907406 D1 DE68907406 D1 DE 68907406D1 DE 8989903719 T DE8989903719 T DE 8989903719T DE 68907406 T DE68907406 T DE 68907406T DE 68907406 D1 DE68907406 D1 DE 68907406D1
Authority
DE
Germany
Prior art keywords
deprenyl
transdermal use
systemic transdermal
systemic
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE8989903719T
Other languages
German (de)
Other versions
DE68907406T2 (en
Inventor
Manfred Karobath
Joerg Reinhardt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somerset Pharmaceuticals Inc
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10634325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68907406(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Application granted granted Critical
Publication of DE68907406D1 publication Critical patent/DE68907406D1/en
Publication of DE68907406T2 publication Critical patent/DE68907406T2/en
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE89903719T 1988-03-29 1989-03-18 DEPRENYL FOR SYSTEMIC TRANSDERMAL USE. Revoked DE68907406T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807504A GB8807504D0 (en) 1988-03-29 1988-03-29 Improvements in/relating to organic compounds

Publications (2)

Publication Number Publication Date
DE68907406D1 true DE68907406D1 (en) 1993-08-05
DE68907406T2 DE68907406T2 (en) 1993-10-14

Family

ID=10634325

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89903719T Revoked DE68907406T2 (en) 1988-03-29 1989-03-18 DEPRENYL FOR SYSTEMIC TRANSDERMAL USE.

Country Status (18)

Country Link
EP (1) EP0404807B1 (en)
JP (1) JP2533211B2 (en)
KR (1) KR0136870B1 (en)
AU (1) AU630088B2 (en)
CA (1) CA1336071C (en)
DE (1) DE68907406T2 (en)
ES (1) ES2013129A6 (en)
FI (1) FI895681A0 (en)
GB (1) GB8807504D0 (en)
GR (1) GR1003711B (en)
HU (1) HU207441B (en)
IE (1) IE62955B1 (en)
IL (1) IL89748A (en)
MY (1) MY105121A (en)
NZ (1) NZ228467A (en)
PT (1) PT90120B (en)
WO (1) WO1989009051A1 (en)
ZA (1) ZA892321B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
DK0695177T3 (en) * 1993-04-20 1998-09-28 Hexal Ag Patch containing active substance
AU707142B2 (en) * 1994-06-03 1999-07-01 David R. Elmaleh Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
HU223475B1 (en) * 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Liposome composition containing selegiline and process for it`s preparation
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
NZ309980A (en) 1995-06-07 2001-06-29 Noven Pharma Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
DE19533089C1 (en) 1995-09-07 1997-05-22 Hexal Ag Tacrine patch
DE19533772C1 (en) * 1995-09-12 1998-01-02 Hexal Ag Tacrine / selegiline patch
IL119417A (en) * 1996-10-13 2003-02-12 Moshe Kushnir Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
WO1999047133A1 (en) 1998-03-16 1999-09-23 Somerset Pharmaceuticals, Inc. Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
DE19814257A1 (en) 1998-03-31 1999-10-07 Asta Medica Ag effervescent formulations
WO2000033812A2 (en) † 1998-12-07 2000-06-15 Elan Corporation, Plc Transdermal patch for delivering volatile liquid drugs
DK1441708T3 (en) 2001-11-05 2009-07-06 Krele Pharmaceuticals Llc Compositions and Methods for Increasing Susceptibility to Therapies Using Aldehyde Dehydrogenase Inhibitors and Treatment of Alcoholism
DE10338174A1 (en) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermal drug formulations with drug combinations for the treatment of Parkinson's disease
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
WO2006058059A2 (en) 2004-11-23 2006-06-01 Neuromolecular Pharmaceuticals, Inc. Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject
BRPI0607017B8 (en) 2005-04-06 2021-05-25 Adamas Pharmaceuticals Inc pharmaceutical composition comprising memantine and donezepil, and their use for the treatment of snc-related conditions
US7846445B2 (en) 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
PT2158908E (en) * 2007-06-21 2013-05-07 Fujimoto Co Ltd Composition for transdermal administration
EP2185701A4 (en) 2007-08-15 2011-03-02 Amunix Operating Inc Compositions and methods for modifying properties of biologically active polypeptides
LT2393828T (en) 2009-02-03 2017-01-25 Amunix Operating Inc. Extended recombinant polypeptides and compositions comprising same
US8957021B2 (en) 2009-02-03 2015-02-17 Amunix Operating Inc. Glucose-regulating polypeptides and methods of making and using same
JP5805634B2 (en) 2009-06-08 2015-11-04 アムニクス オペレーティング インコーポレイテッド Growth hormone polypeptides and methods of making and using the same
CA2772051C (en) 2009-08-24 2020-08-18 Amunix Operating Inc. Coagulation factor ix compositions and methods of making and using same
WO2011069010A2 (en) 2009-12-02 2011-06-09 Adamas Pharmaceuticals, Inc. Amantadine compositions and methods of use
DE102010024105A1 (en) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermal administration of memantine
ES2935489T3 (en) 2012-02-15 2023-03-07 Bioverativ Therapeutics Inc Factor VIII compositions and methods of preparation and use thereof
KR102008190B1 (en) 2012-02-15 2019-08-07 바이오버라티브 테라퓨틱스 인크. Recombinant factor viii proteins
US10154971B2 (en) 2013-06-17 2018-12-18 Adamas Pharma, Llc Methods of administering amantadine
US10548953B2 (en) 2013-08-14 2020-02-04 Bioverativ Therapeutics Inc. Factor VIII-XTEN fusions and uses thereof
EA201890423A1 (en) 2015-08-03 2018-07-31 Биовератив Терапьютикс Инк. SLIGHT PROTEINS OF THE FACTOR IX, METHODS OF THEIR RECEPTION AND APPLICATION
US20180104250A1 (en) 2016-10-14 2018-04-19 Knowles Enterprises Inc. Formulations for treatment of migraines
WO2018200885A1 (en) 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139127A1 (en) * 1983-08-22 1985-05-02 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Transdermal drug delivery device and its preparation
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
EP0241809B1 (en) * 1986-04-16 1990-08-08 ASTA Pharma Aktiengesellschaft Synergistic association of amantadine and selegiline

Also Published As

Publication number Publication date
JP2533211B2 (en) 1996-09-11
WO1989009051A1 (en) 1989-10-05
AU3290089A (en) 1989-10-16
AU630088B2 (en) 1992-10-22
MY105121A (en) 1994-08-30
GR1003711B (en) 2001-10-25
GB8807504D0 (en) 1988-05-05
PT90120B (en) 1994-06-30
EP0404807B1 (en) 1993-06-30
FI895681A0 (en) 1989-11-28
EP0404807A1 (en) 1991-01-02
GR890100190A (en) 1990-01-19
IE62955B1 (en) 1995-02-20
ES2013129A6 (en) 1990-04-16
ZA892321B (en) 1990-12-28
HUT55220A (en) 1991-05-28
KR0136870B1 (en) 1998-04-25
CA1336071C (en) 1995-06-27
DE68907406T2 (en) 1993-10-14
PT90120A (en) 1989-11-10
IL89748A (en) 1993-07-08
JPH02503677A (en) 1990-11-01
HU207441B (en) 1993-04-28
KR900700089A (en) 1990-08-11
NZ228467A (en) 1991-12-23
HU892559D0 (en) 1990-01-28
IE890921L (en) 1989-09-29

Similar Documents

Publication Publication Date Title
DE68907406D1 (en) DEPRENYL FOR SYSTEMIC TRANSDERMAL USE.
DE69019213T2 (en) Skin clip.
DE68914604D1 (en) Wound dressing.
DE68907553D1 (en) MAKE-UP AGENTS FOR HUMAN USE.
ATE98495T1 (en) MEDICATIONS FOR TOPICAL USE.
NO862236D0 (en) VOICE ACTIVATED ECOGOGENERATOR.
DE68905532T2 (en) Dental adhesive mixture.
DE58900280D1 (en) CLAMPING DEVICE.
DE68912332D1 (en) Wound bandage.
FI921121A0 (en) TRANSDERMAL DOSERINGSANORDNING MED FOERDROEJD START.
DE58906056D1 (en) CURLER.
DE58904620D1 (en) CLAMPING DEVICE.
DE58904398D1 (en) CLAMPING DEVICE.
DE68910299D1 (en) Spread.
ATE91076T1 (en) DEPRENYL FOR SYSTEMIC TRANSDERMAL USE.
NO890120D0 (en) MATERIAL FORM INSTRUCTIONS.
DE58905034D1 (en) HANDMADE KNABBER.
DE58900488D1 (en) CLAMPING DEVICE.
DE69014506T2 (en) External preparation.
IT1235096B (en) PERFECTED WHEEL SUPPORT.
ES1004205Y (en) PERFECTED CALENDAR.
ES1002675Y (en) PERFECTED VALVE
DE58903188D1 (en) CLAMPING DEVICE.
ES1006246Y (en) PERFECTED SCISSORS.
ES1006018Y (en) HAIR CLIP.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation